Key Points
- FDA posts pouch environmental review;
- Covers “other” nicotine products;
- Agency says impacts are minimal;
- Assessment may affect PMTA reviews.
2Firsts
May 21, 2026
As of May 21, 2026 ET, The U.S. Food and Drug Administration (FDA) released a Programmatic Environmental Assessment covering nicotine pouches and other nicotine products categorized as “other.”
FDA said the assessment is part of its review process for Premarket Tobacco Product Applications (PMTAs), which requires the agency to evaluate the environmental effects of authorizing new tobacco products for sale.
Products included in the “other” category covered by the assessment include:
- nicotine pouches;
- lozenges;
- nicotine tablets;
- nicotine gums;
- dissolvable tobacco products;
- and other nicotine-infused products.
However, FDA specifically excluded traditional smokeless tobacco products such as:
- dip;
- snuff;
- snus;
- and chewing tobacco.
According to the agency, existing scientific evidence suggests these products generally have “minimal” environmental effects.
FDA explained that because these products do not produce airborne emissions during use, they can reduce or eliminate:
- secondhand exposure;
- and thirdhand exposure.
The agency also said waste generated from these products contains relatively few harmful chemicals that:
- leach into the environment;
- persist over time;
- or bioaccumulate.
FDA said publication of the environmental assessment is part of its broader commitment to regulatory transparency.
The agency added that the document may also be cited by FDA scientific reviewers during future PMTA evaluations.
FDA emphasized that although the assessment broadly applies to the “other” product category, each tobacco product application will still be reviewed individually based on the specific evidence submitted.
Under FDA procedures, when a new tobacco product receives authorization, the agency typically publishes:
- an Environmental Assessment;
- a Finding of No Significant Impact (FONSI);
or
- an Environmental Impact Statement.
The U.S. nicotine pouch market has continued expanding rapidly in recent years.
Major brands including PMI’s ZYN, Altria’s on!, and Reynolds American’s VELO continue increasing their presence in the market.
Industry observers said the environmental assessment signals that FDA is continuing to refine its regulatory framework for nicotine pouches and other oral nicotine products.
Analysts added that while the document does not itself authorize products for sale, it may influence future PMTA review processes, regulatory expectations, and industry planning.
(Cover Image source: FDA)
This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.
